Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-01

Clinical Trial Update: Validation of Ferromagnetic Tracer in Melanoma Sentinel Node

View source ↗

Summary

This clinical trial update discusses validation of a ferromagnetic tracer for sentinel lymph node mapping in melanoma. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferromagnetic Tracer (ferromagnetic tracer)

Snippet

Sponsor: Sociedad Española de Oncología Quirúrgica | Conditions: Melanoma Stage, Sentinel Lymph Node | Status: UNKNOWN